Steve Moore, ACI Strategic Counsel has today responded to the National Pharmacy Association’s advisory statement regarding CBD products in pharmacies with the following statement:
“Today, the Association for the Cannabinoid Industry welcomes the call for improved CBD regulations from the National Pharmacy Association.
Our organisation and existing members are unequivocally committed to achieving Novel Foods status via the Food Standards Agency (FSA) taking us closer to a standardised framework for a legal, safe and regulated cannabinoid industry in the UK. We created the new Association for the Cannabinoid Industry (ACI) to help foster a legally compliant, socially responsible and innovative CBD industry. We urge CBD companies and stakeholders across the UK to sign up to the ACI Quality Charter.
Ultimately, through the ACI Charter, we are working towards the introduction of a kitemark to display on CBD products to provide consumers with reassurance that their purchase is meeting the regulations. Shoppers should feel confident about the quality of the CBD products on offer in retail – and the fact that they are ‘getting what they pay for”